Subgroup classification of receptor tyrosine kinase (RTK) pathway activation in KRAS-mutated metastatic carcinoma.

e18019 Background: Molecular stratification of metastatic carcinoma in body fluids has become critical to therapy selection, as these are often the only accessible disease sites. We performed multi...